Searched for
PFIZER Q1
Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20%Pfizer India's shares surged after reporting strong Q3FY26 results, with net profit up 11% and revenue by 20%. The company also recorded ex...- Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...
- Millions set to get 80% off prescription drugs as White House rolls out ‘TrumpRx’ planPresident Donald Trump has launched TrumpRx, a direct-to-consumer website created to make prescription medications up to 80% cheaper for Am...
- PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 billion Metsera weight-loss acquisitionPfizer Inc. (NYSE: PFE) experienced a significant uptick in its stock price following two major announcements on September 30, 2025. Presid...
- Pfizer PFE stock, Metsera MTSR stock: Pfizer, Metsera share prices jump as deal worth over $7 billion gets thumbs upStock Market boom for both companies' shares came as Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up t...
- US stock market today: Dow, S&P 500, Nasdaq Pull Back from record highs as Gold hits fresh all-time peakUS stocks fell slightly as investors waited for Fed speeches and key inflation data. Gold hit a record high while Bitcoin and other cryptoc...
- Pfizer stock soars as earnings smash expectations, and company raises outlookPFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...
- Pfizer exceeds Q4 earnings estimates as covid product sales outperform expectationsStrong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...
- Q4 Results Roundup: How Kalyan Jewellers, Tube Investments, Pfizer India, Karur Vysya Bank faredTube Investments reported a rise of 84% in net profit, reaching Rs 251 crore. Pfizer India saw a marginal increase in net profit to Rs 130 ...
- Pfizer Q1 Results: Profit falls 83% to Rs 33 croreRevenue from operations declined to Rs 593 crore in the quarter from Rs 749 crore in the year-ago period.The drug firm said exceptional ite...
- Pfizer Q1 results: Net profit up 61% to Rs 200 croreRevenue from operations of the company stood at Rs 749.17 crore for the quarter under consideration. It was Rs 514.89 crore for the same pe...
- Hold Pfizer, target price Rs 4,665: Anand RathiThe pharma major launched its patented product, Zavicefta, in India in H1 FY20. This was the first anti-infective drug launched by Pfizer i...
- Stocks in the news: YES Bank, TCS, Ashok Leyland, Raymond, Pfizer and IL&FS TransportHere are a few stocks which by buzz the most in today's trade.
- Pfizer Q1 net profit up 61% to Rs 92 croreStandalone revenue from operations of the company stood at Rs 512.31 crore for the April-June quarter.
- Buy Pfizer, target Rs 2900: Centrum BrokingBuy Pfizer Ltd. at a price target of Rs 2900.
- Pfizer Q1 net profit dips 3% at Rs 46 croreNet sales of the company, however, rose to Rs 239.85 crore during the first quarter, as compared to Rs 237.53 crore in the same period of p...
- Pfizer Q2 net profit up 33% at Rs 69.59 crorePfizer today reported 33.11 pc rise in standalone net profit to Rs 69.59 cr for the second quarter ended September 30, 2013-14 fiscal.
- Pfizer Q4 net up 21% at Rs 58 croreDrug firm Pfizer Ltd on Tuesday posted 20.91 per cent increase in net profit at Rs 58.16 crore for its fourth quarter ended March 31, 2013.
- Ranbaxy gets US patent office booster dose in Lipitor caseIn what would give a leg up to Ranbaxy, the US Patent and Trademark Office (USPTO) has rejected Pfizer’s appeal to re-issue patent for its ...
- Pfizer Q2 up two fold at Rs 35.89 crGlobal pharmaceutical company, Pfizer Ltd on Wednesday posted an increase of over two fold in net profit after tax at Rs 35.89 crore for th...
Load More
